We recently reported that the single repeating-unit pentasaccharide of type III group B Streptococcus (GBS) capsular polysaccharide is only weakly reactive with type III GBS antiserum. To further elucidate the relationship between antigen-chain length and antigenicity, tritiated oligosaccharides derived from type HI capsular polysaccharide were used to generate detailed saturation binding curves with a fixed concentration of rabbit antiserum in a radioactive antigenbinding assay. A graded increase in affinity of antigenantibody binding was seen as oligosaccharide size increased from 2.6 repeating units to 92 repeating units. These differences in affinity of antibody binding to oligosaccharides of different molecular size were confirmed by immunoprecipitation and competitive ELISA, two independent assays of antigen-antibody binding. Analysis of the saturation binding experiment indicated a difference of 300-fold in antibodybinding affinity for the largest versus the smallest tested oligosaccharides. Unexpectedly, the saturation binding values approached by the individual curves were inversely related to oligosaccharide chain length on a molar basis but equivalent on a weight basis. This observation is compatible with a model in which binding of an immunoglobulin molecule to an antigenic site on the polysaccharide facilitates subsequent binding of antibody to that antigen.
between antigen-chain length and antigenicity, tritiated oligosaccharides derived from type HI capsular polysaccharide were used to generate detailed saturation binding curves with a fixed concentration of rabbit antiserum in a radioactive antigenbinding assay. A graded increase in affinity of antigenantibody binding was seen as oligosaccharide size increased from 2.6 repeating units to 92 repeating units. These differences in affinity of antibody binding to oligosaccharides of different molecular size were confirmed by immunoprecipitation and competitive ELISA, two independent assays of antigen-antibody binding. Analysis of the saturation binding experiment indicated a difference of 300-fold in antibody- have been isolated from human urine and identified on human glycoproteins; yet, the type III polysaccharide is immunogenic in most human subjects, and cross-reactions with host antigens have not been seen (1) (2) (3) . Our previous investigations suggested that the polymeric structure of this bacterial polysaccharide, in addition to its primary repeating-unit structure, might be a critical factor in the host's ability to discriminate between the bacterial polysaccharide and homologous host oligosaccharides. We have recently reported that a pentasaccharide complete single repeating-unit oligosaccharide derived from the type III group B Streptococcus (GBS) capsular polysaccharide is very weakly antigenic (4) . A double repeating-unit oligosaccharide was more antigenic than the single repeating-unit oligosaccharide but less so than the native polysaccharide, suggesting that antigenicity depended on antigen-chain length (4) .
The current studies were undertaken to define the relationship between antigenicity and molecular size in this model system. In particular, we sought to estimate relative affinities of antigen binding to type III GBS antibody for oligosaccharides of different sizes. Large binding-affinity differences between antibody and large-Mr versus small-Mr antigens of the same repeating structure might represent a mechanism for host immune recognition of a bacterial polysaccharide as distinct from homologous oligosaccharides on host glycoproteins. By measuring antigen-antibody binding over a range of oligosaccharide concentrations for each of four oligosaccharides, we generated saturation binding curves for each oligosaccharide. Analysis of these curves has confirmed large differences in affinity of binding of small oligosaccharides versus large oligosaccharides to type III GBS antiserum. These results were confirmed by two independent immunologic assay methods. In addition, mathematical modeling based on these data suggests that antibody binding to one immunodeterminant site on GBS polysaccharide results in a dramatic increase in the antibody binding affinity of other immunodeterminant sites on the same polysaccharide molecule. This model may explain the high affinity of antigen-antibody interactions for many polysaccharide antigens.
MATERIALS AND METHODS
Type III GBS capsular polysaccharide (5) and derivative oligosaccharides (4, 6) were prepared and radiolabeled (7, 8) as described. Type III GBS antiserum was raised in New Zealand White rabbits as described using type III GBS strain M732 (9) . IgG was adsorbed from this serum on a column of protein A-Sepharose and eluted with 0.1 M glycine HCl, pH 3.0. Radioactive antigen binding assay (RABA) (10) and ELISA inhibition assays (11) have been described.
Statistical Analysis of Saturation Binding Curves. We modeled the relationship between y, the amount of antigen bound (in ng) for each oligosaccharide antigen of molecular size s (in ng/pmol), and x, the amount of antigen added (in ng) using a logistic-type regression (12) as follows: ln[y./(c, -Ys)] = a, + bsln(x/s) + e [1] where (x/s) is in pmol and the e values are independent and normally distributed with mean 0 and unknown variance r2.
The parameter cs stands for the amount of antigen bound when the antigen-binding sites of the antiserum are saturated (i.e., the amount of antigen bound for an infinite concentration of antigen); the exp(as) [ Fig. 1 . We measured the amount of antigen bound by a fixed amount of antiserum over a range of antigen concentrations for each of four oligosaccharides of different chain length. Initially we assumed that, in the presence of excess antigen, not more than one antibody molecule would be bound to each antigen molecule (14) . If all oligosaccharides were capable of binding to the same population(s) of antibody, we expected all the saturation curves to approach the same asymptote but at different rates depending on relative affinities. In other words, at a theoretically infinite antigen concentration, the number of moles of antigen bound by a fixed amount of antiserum should be the same, regardless of antigen size. Surprisingly, simple inspection of the binding curves shown in Fig. 1 suggests the number of moles of antigen bound at saturation is very different for oligosaccharides of different sizes.
To generate an objective estimate of "saturation" binding, we fit a mathematical model of the type described by Eq. 1 separately for each oligosaccharide to estimate the value of the asymptote approached by each curve. Like any mathematical model, the function generated is only an approximation of the true binding interaction(s); it treats as a single function the interaction of a multivalent antigen with, potentially, several populations of antibodies with different binding characteristics. To the extent that such factors influence antigen-binding capacity of the antiserum and overall affinity of binding, they will be reflected, in an unbiased way, in the curve generated by the regression model. When the curves were fit in this manner to the data points shown in Fig. 1 calculated asymptote, c, or the number of moles of antigen bound to antibody at a theoretically infinite antigen concentration, increased from 1.7 pmol for the largest oligosaccharide to 48 pmol for the smallest. An explanation for this result was suggested by the observation that calculating the amount of antigen bound for each oligosaccharide in units of mass, rather than moles, resulted in c values for each oligosaccharide that agreed closely with one another (Table 1) . That is, the amount of antigen bound on a weight basis, at saturation, appeared to be essentially independent of oligosaccharidechain length. Fig. 2 shows the same data as Fig. 1 with antigen bound expressed in terms of antigen mass, rather than moles, along with the curve calculated by Eq. 1 to give the best fit to the data points for each oligosaccharide. In A, the curves have been fit by application of Eq. 1 to the binding data for each oligosaccharide independently. The asymptote (c) values for these curves are those shown in Table 1 . In B, the curves were fit imposing a single asymptote (c) value for all the curves simultaneously. Casual inspection of the two sets of curves, as well as statistical comparison (likelihood-ratio statistic = 0.16, df = 3, p value = 0.98), shows no difference between the fit ofthe curves generated by using the individual estimates for c calculated on the binding data for each oligosaccharide independently versus that calculated imposing a common value for c. In other words, when antigen bound is expressed in units of mass, antigen-binding capacity of the antiserum appears the same for each oligosaccharide, regardless of antigen-chain length. Particularly for the smaller oligosaccharides, the actual data points span only a portion of the predicted binding curve, resulting in some uncertainty in the estimate of the asymptote value, as is evident from the width of the confidence intervals in the table. Given this uncertainty, it is remarkable that independent estimates of the asymptote binding value for each of the oligosaccharides should agree so closely in terms of mass of antigen bound. (Fig. 3) . Statistical comparison of theoretical curves generated using a single common value for c (the saturation binding asymptote) for all the curves versus separate values for c generated by the binding data for each oligosaccharide showed no difference in fit (likelihood ratio statistic = 1.29, df = 2, p value = 0.52). Binding capacity (c value) of the purified IgG fraction was 74% of that calculated from the RABA experiments using whole serum, suggesting that the type III antibodies in this serum are predominantly of the IgG class. These data independently confirm the original observation that the amount of antigen bound by antibody approaches the same value on a weight basis rather than a molar basis, with increasing antigen concentration for oligosaccharides of different molecular size. (11, 16) . Over a range of inhibitor concentrations, curves were generated for the native polysaccharide and each of the oligosaccharides (Fig. 4) . These inhibition profiles revealed a similar relationship to molecular size of the inhibiting antigen as that observed in the RABA saturation binding studies. The magnitude of the relative affinity differences was even more dramatic in the ELISA inhibition experiments than in the RABA saturation binding studies. These results provided further support for the affinity differences seen in the RABA experiments. Moreover, the ability of the oligosaccharides to compete for antibody binding with the higher-Mr form of the antigen indicates that the smaller oligosaccharides bind to the same population of antibodies as does the native polysaccharide but bind with lower affinity.
Molecular Size of Immune Complexes. The model we propose (see below) of high-affinity binding of antibody to a polysaccharide antigen predicts the formation of high-Mr immune complexes consisting of multiple antibody molecules bound to a single antigen molecule, even when antigenantibody interaction occurs in antigen excess. We confirmed the formation of high-Mr complexes experimentally by Sepharose-CL6B chromatography of immune complexes formed by the reaction of 3H-labeled type III polysaccharide (at a 6-fold molar excess) with IgG purified from type III GBS antiserum. The elution profile of ammonium sulfate-precipitable radioactivity (representing [3H]polysaccharide bound to antibody) is shown in Fig. 5 . When run separately, the [3H]polysaccharide and the IgG preparation elute in single peaks corresponding to Mr of 110,000 and 150,000, respectively. Immune complexes ofa single IgG molecule combined with a molecule of polysaccharide would be predicted to yield a peak corresponding to Mr 200,000-300,000, as in peak 2 (Mr 220,000). In addition, however, a peak is seen in V. of the CL-6B column (peak 1), indicating immune complexes of Mr dence demonstrating that the affinity of antibody binding to the type III GBS capsular polysaccharide is determined by antigen-chain length. This relationship between affinity of antibody binding and antigen chain length was seen in three different immunologic assays: RABA, protein A immunoprecipitation, and ELISA inhibition. In addition, analysis of oligosaccharide saturation binding curves by mathematical modeling indicated that a given amount of antibody bound the same mass (rather than molar amount) of antigen in extreme antigen excess, regardless of antigen-chain length. We propose the following model of antigen-antibody interaction to explain these findings: the affinity of binding of antibody to the polysaccharide is relatively low; however, binding of one immunoglobulin molecule to a site on the polysaccharide leads to a marked increase in the affinity of interaction between adjacent immunodeterminant sites and other immunoglobulin molecules. Subsequent binding of antibody will tend to be on molecules that have already bound antibody, whereas the interaction with "naive" polysaccharide molecules will be infrequent because of the lower affinity of their immunodeterminant sites. Thus, a chain reaction might be initiated on a large polysaccharide bearing multiple immunodeterminant sites, such that antibody would preferentially bind to all available sites on a given molecule before binding to the lower-affinity sites on a naive molecule.
This model is analogous to the concept of positive cooperativity in ligand-receptor binding. Evidence compatible with such a mechanism has recently been reported by Greenspan et al. (17) Immunology: Wessels et al. 1 .0 ma1 r of the complexes to be a single broad peak with a maximum at the molecular size representing the most prevalent form of complexes (15 (19, 20) . However, Goodman et al. (21) found that a mixture of peptides derived from the poly(D-glutamic acid) capsule of Bacillus anthracis with an average polymer size of nine amino acids was 4-fold more efficient than the homologous hexapeptide in inhibition of the poly(D-glutamic acid) quantitative precipitin reaction. Similarly, Jennings et al. (7) found oligomers of a-(2--8)-linked sialic acid oligosaccharides increasingly antigenic to chain length of at least 17 residues in inhibiting the quantitative precipitin reaction between group B meningococcal antiserum and colominic acid.
The mechanism for increased affinity of antibody binding to high-Mr forms of these antigens is unknown. Some increase in avidity of binding is anticipated as antigen-chain length increases sufficiently to permit simultaneous interaction of both Fab regions of IgG molecules with separate immunodeterminant sites on the antigen. However, we saw further graded increases in affinity ofbinding as antigen-chain length increased beyond that expected to accommodate bivalent antibody binding (i.e., beyond a backbone-chain length of 10-20 sugar residues, or 3-6 repeating units). The high-Mr form of the type III GBS capsular polysaccharide thus seems to be associated with a conformation of the repeating immunodeterminant that binds antibody with high affinity. One implication of these findings is that antibodies with a binding-site specificity for a small oligosaccharide may functionally discriminate between simple haptens consisting of that oligosaccharide and a polysaccharide of multiple repeating units of the same oligosaccharide. Binding interaction with an oligosaccharide on a host glycoprotein would be of very low affinity, insufficient to result in activation of potentially damaging immune effector mechanisms. Antibody interaction with the same oligosaccharide structure as part of a bacterial capsular polysaccharide would lead to high-affinity binding of antibody molecules to other immunodeterminant sites on the polysaccharide, with subsequent activation of immune effector mechanisms.
